NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 181 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $492,000 | -0.2% | 44,846 | 0.0% | 0.01% | +83.3% |
| Q1 2015 | $493,000 | -32.4% | 44,846 | -4.6% | 0.01% | 0.0% |
| Q4 2014 | $729,000 | -37.7% | 47,016 | -51.5% | 0.01% | -40.0% |
| Q3 2014 | $1,171,000 | -3.5% | 96,978 | +2.5% | 0.01% | -80.4% |
| Q2 2014 | $1,213,000 | +17.5% | 94,653 | +11.1% | 0.05% | +10.9% |
| Q1 2014 | $1,032,000 | -7.8% | 85,164 | -13.6% | 0.05% | +64.3% |
| Q4 2013 | $1,119,000 | +35.8% | 98,598 | +25.0% | 0.03% | +16.7% |
| Q3 2013 | $824,000 | -15.0% | 78,883 | -5.9% | 0.02% | +71.4% |
| Q2 2013 | $969,000 | – | 83,862 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |